Friday, May 13, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Evolutionary history of ACE2 binding across a diverse range of sarbecoviruses and ACE2 orthologs

by Medical Finance
in Coronavirus
Study: ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. Image Credit: Kateryna Kon/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

It is well known that coronavirus disease 2019 (COVID-19) is a zoonotic disease. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, did not initially infect humans. The exact path the disease took before jumping to humans is controversial. Despite early media attention that the disease began in bats, alternate theories have gained strong traction, including the idea that the disease might have made multiple host jumps, even infecting humans in an earlier form before the pandemic began.


Study: ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. Image Credit: Kateryna Kon/ShutterstockStudy: ACE2 binding is an ancestral and evolvable trait of sarbecoviruses. Image Credit: Kateryna Kon/Shutterstock


In a study published in Nature, researchers have been investigating sarbecovirus lineages and the ability of those lineages to evolve the ability to bind angiotensin-converting enzyme 2 (ACE2).


The study


The researcher assembled a gene library encoding the receptor-binding domains (RBDs) of 45 sarbecovirus’, spanning all known RBD phylogenetic clades. This library was then cloned into a yeast surface display platform to enable high-throughput measurement of ACE2 binding avidities through titration assays combining fluorescence-activated cell sorting (FACS) and deep sequencing. A panel of recombinant dimeric ACE protein from four humans, civets, pangolins, and mice, as well as two alleles from two different species of bats (R.affinis and R. sinicus) was also assembled. The dissociation constant (KDapp) of each RBD for each ACE2 ortholog was measured in duplicate using independently constructed libraries.


As expected, human ACE2 was most strongly bound by the human sarbecovirus’ SARS-CoV-1 and SARS-CoV-2, followed closely by similar diseases to SARS-CoV-2 commonly found in pangolins. The RBD from the bat virus RaTG13 showed much lower affinity, as did the RBD’s from civet diseases. A bat virus closely resembling SARS-CoV-1 showed a very similar binding affinity to hACE2 as SARS-CoV-1, even higher in some cases. Only viruses’ in the SARS-CoV-1 clade could successfully bind to the civet ACE2, and pangolin ACE2 binding was far more commonly seen in the SARS-CoV-2 clade. In bats, R, Affinis, and R. Sinicus ACE2 showed very varied binding to RBD from both clades – which the researchers suggest is due to an evolutionary arms race. Strangely, the BtKY72 virus from Kenya could also bind to R. Affinis ACE2 – the only non-Asian sarbecovirus that could.


The results from the BtKY72 virus lead the scientists to believe that ACE2 binding was present in the ancestor of all sarbecovirus’ before the clades split. To test this, they used ancestral sequence reconstruction to infer plausible sequences that would represent ancestral nodes on the RBD phylogeny and then evaluated ACE2 binding for the most probable reconstructed sequences. They found that the reconstructed ancestor could also bind the R. affinis ACE2 allele (as well as broader ACE2 binding, including hACE2), but this binding was then lost along the branch to the clade 2 ancestor. 


The researchers then constructed mutant libraries in 14 RBD backgrounds spanning the RBD phylogeny to explore how easily RBDs can acquire the ability to bind ACE2 due to single amino acid mutations. They then introduced the mutations at six positions that the previous experiments implicated strongly in the evolution of receptor binding. The results show that ACE2 binding evolves very easily, and in almost every case in which a parental RBD binds ACE2, a single mutation can improve that binding 5-fold. In cases where a parental RBD does not bind ACE2, low-to-moderate binding is easily conferred.


As ACE2 binding is an ancestral trait that is easily evolved, unsampled sarbecovirus’ are likely to evolve easily to bind ACE2. To test this, the researchers investigated viruses from Africa and Europe that were reported after the initiation of the study. They found that two newly described sarbecovirus’ from Russia could bind R. affinis ACE2 easily, and one could bind to hACE2 even without any additional mutations


The conclusion


The authors highlight that they have shown that binding to ACE2 is an easily evolvable trait initially present in the common ancestor of SARS-CoV-1 and SARS-CoV-2, suggesting that this could explain the sarbecovirus lineages propensity for host jumps. The simplicity of the mutations that can confer the ability to bind hACE2 to other sarbecovirus’ suggests that it is likely that more will be able to infect humans in the future, as the barriers between human populations and animal habitats continue to thin – although hopefully not in as devastating a manner as SARS-CoV-2. The researchers’ findings could be very useful to those studying zoonotic diseases and could be considered an early warning to prepare for additional lineages evolving the ability to infect humans.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: The Investigation of Pulmonary Abnormalities using Hyperpolarised Xenon Magnetic Resonance Imaging in Patients with Long-COVID. Image Credit: SvetaZi/Shutterstock

Hp-XeMRI identifies impaired gas transfer in lungs of non-hospitalised breathless Long-COVID patients with normal CT scans

by Medical Finance
May 13, 2022
0

Coronavirus disease 2019 (COVID-19) causes symptoms such as anosmia, coughing, headaches to more deadly results such as organ failure...

Study: Iga Vasculitis And COVID-19 In Children: A Systematic Review. Image Credit: NIAID

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

by Medical Finance
May 13, 2022
0

In a recent study posted to the Research Square* preprint server, researchers conducted a systematic review to investigate any association...

Study: Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022. Image Credit: LBeddoe/Shutterstock

Comparison of school protocols under the high incidence conditions due to the Omicron variant

by Medical Finance
May 13, 2022
0

Now that the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly and extensively,...

Study: High antibody and reduced cellular response in children up to one year after SARS-CoV-2 infection. Image Credit: L Julia/Shutterstock

Study explores differential immune responses against SARS-CoV-2 in adults and children

by Medical Finance
May 13, 2022
0

A recent study posted to the Research Square* preprint server, and currently under consideration at a Nature Portfolio Journal, revealed...

Study: Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins. Image Credit: Kateryna Kon/Shutterstock

Memory B cells found to potently neutralize SARS-CoV-2 Omicron variant

by Medical Finance
May 13, 2022
0

In a recent study posted to the bioRxiv* pre-print server, a team of researchers captured memory B cells from a...

An in silico approach for screening herbal leads for potential inhibitors of the viral main protease enzyme in order to discover new antiviral therapies against SARS-CoV-2.

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

by Medical Finance
May 13, 2022
0

In a recent study posted to the Research Square preprint* server, a team of researchers investigated the toxicity and absorption,...

Next Post
General Internal Medicine and Geriatrics officially separated into two divisions

General Internal Medicine and Geriatrics officially separated into two divisions

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Researchers pursue a new way to use milk for delivering cancer-fighters to the brain

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. Image Credit: joshimerbin/Shutterstock
    Sotrovimab found to prevent hospitalization and mortality in COVID-19 outpatients
  • Study: Development of monoclonal antibodies to detect for SARS-CoV-2 proteins. Image Credit: ustas7777777 / Shutterstock.com
    Development of 18 monoclonal antibodies against 9 SARS-CoV-2 proteins
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply